Yu Chang

Dr. Yu Chang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2017 in Langmuir
Verified
Journal Article
Closed access
YCYing-Nien Chou
Ying-Nien Chou
Antoine VenaultAntoine Venault
Antoine Venault
CCChia-Ho Cho
Chia-Ho Cho
MSMei-Chan Sin
Mei-Chan Sin
LYLu-Chen Yeh
Lu-Chen Yeh
Antoine VenaultAntoine Venault
Antoine Venault

27 May 2014 in Langmuir
Verified
Journal Article
Closed access
YSYu-Ju Shih
Yu-Ju Shih
Antoine VenaultAntoine Venault
Antoine Venault
Damien QuemenerDamien Quemener
Damien Quemener
HYHui-Shan Yang
Hui-Shan Yang
JJJheng-Fong Jhong
Jheng-Fong Jhong
YCYu Chang
Yu Chang

24 February 2015 in Langmuir
Verified
Journal Article
Closed access
Antoine VenaultAntoine Venault
Antoine Venault
YZYong-Sheng Zheng
Yong-Sheng Zheng
ACArunachalam Chinnathambi
Arunachalam Chinnathambi
SASulaiman Ali Alharbi
Sulaiman Ali Alharbi
HHHsin-Tsung Ho
Hsin-Tsung Ho
Antoine VenaultAntoine Venault
Antoine Venault

28 February 2023 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
HLHsin-Chieh Lin
Hsin-Chieh Lin
CWChih-Chun Wang
Chih-Chun Wang
CWChing-Fang Wu
Ching-Fang Wu
YLYuan-Ho Lin
Yuan-Ho Lin
WLWei-Chang Lee
Wei-Chang Lee
YSYu Chieh Su
Yu Chieh Su
Background/Aim: Oral squamous cell carcinoma (OSCC) is one of the deadliest cancers, with approximately ~500,000 new diagnosed cases and 145,000 deaths worldwide, per year. The incidence of new cases continues to increase in developing countries. This study aimed to investigate the effect of hinokitiol on cell viability in OSCC cells. Materials and Methods: The anticancer effect and mechanism of action of hinokitiol in OSCC cells were analyzed by cell viability assays and cell cycle analysis using flow cytometry, while apoptosis and autophagy-related protein expression was measured using western blot. Results: The results showed that hinokitiol concentration-dependently reduced the viability of SCC4 and SCC25 cells by downregulating the levels of cell-cycle mediators, such as cyclin B1, cyclin D1 and cyclin-dependent kinase-1 (CDK1). Furthermore, hinokitiol promoted apoptosis in SCC25 cells based on the presence of active cleaved caspase-3. Hinokitiol also induced autophagy by promoting the accumulation of the microtubule-associated protein light chain 3B (LC3B) and the expression of the sequestosome-1 (p62/SQSTM). Conclusion: Hinokitiol exhibits anti-proliferation activity and has pro-apoptotic effects on OSCC cell lines.

10 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LCLiang-Chun Chiu
Liang-Chun Chiu
CLChih-Wen Lin
Chih-Wen Lin
HLHung-Ju Li
Hung-Ju Li
JCJian-Han Chen
Jian-Han Chen
FCFu-Cheng Chuang
Fu-Cheng Chuang
YSYu Chieh Su
Yu Chieh Su
A continuous increase in follicular lymphoma has been observed in Taiwan, Japan, and South Korea over the last few decades. This study aimed to evaluate the difference in incidence trends of follicular lymphoma in Taiwan, Japan, and South Korea between 2001 and 2019. The data for the Taiwanese populations was obtained from the Taiwan Cancer Registry Database, and those for the Japanese and Korean population were retrieved from the Japan National Cancer Registry and some additional reports, both of which included population-based cancer registry data, from Japan and Korea. Follicular lymphoma accounted for 4231 cases from 2002–2019 in Taiwan, 3744 cases from 2001–2008 and 49,731 cases from 2014–2019 in Japan; and 1365 cases from 2001–2012 and 1244 cases from 2011–2016 in South Korea. The annual percentage change for each time period was 3.49% (95% confidence interval: 2.75–4.24%) in Taiwan, 12.66% (95% confidence interval [CI]: 9.59–15.81%) and 4.95% (95% CI: 2.14–7.84%) in Japan, and 5.72% (95% CI: 2.79–8.73%) and 7.93% (95% CI: −1.63–18.42%) in South Korea. Our study confirms that the increasing trends of follicular lymphoma incidence in Taiwan and Japan have been remarkable in recent years, especially the rapid increase in Japan between 2014 and 2019; however, there was no significant in-crease from 2011 to 2015 in South Korea.

Pooja SharmaPooja Sharma
Pooja Sharma
JLJo-Yu Lynn Lee
Jo-Yu Lynn Lee
ETEing Mei Tsai
Eing Mei Tsai
YCYu Chang
Yu Chang
Jau-Ling SuenJau-Ling Suen
Jau-Ling Suen
Endometriosis is an inflammatory and estrogen-dependent gynecological disease associated with exposure to environmental endocrine disruptors. n-Butyl benzyl phthalate (BBP), a ubiquitous plasticizer, has weak estrogenic activity, and exposure to BBP is associated with endometriosis. We aimed to elucidate the immunomodulatory effect of BBP on endometriosis development. We previously established a surgery-induced endometriosis-like murine model. In the present study, we exposed those mice to BBP 10 days prior to surgery and 4 weeks after surgery at physiologically relevant doses to mimic human exposure. Chronic exposure to BBP did not promote the growth of endometriotic lesions; however, the lesion survival rate in BBP-treated mice did increase significantly compared with control mice. Multiparametric flow cytometry showed that BBP exposure did not affect the homeostasis of infiltrated immune subsets in lesions but did enhance CD44 (adhesion marker) expression on plasmacytoid dendritic cells (pDCs). Blocking CD44 interactions locally inhibited endometriotic lesion growth. Immunofluorescence results further confirmed that CD44 blocking inhibited pDC infiltration and reduced the frequency of CD44+ pDCs in endometriotic tissues. BBP also disrupted the estrus cycle in these mice. This study suggests that chronic exposure to low-dose BBP may promote survival of endometriotic tissue through CD44-expressing pDCs.